These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 10838455

  • 1. New rearrangement pattern after treatment of hairy-cell leukemia with 2-chlorodeoxyadenosine.
    Schirmer M, Haun M, Grünewald K, Geisen F, Hilbe W, Thaler J, Konwalinka G.
    Acta Haematol; 2000; 103(2):109-11. PubMed ID: 10838455
    [Abstract] [Full Text] [Related]

  • 2. Molecular evaluation of clonal remission in hairy cell leukemia patients treated with 2-chlorodeoxyadenosine.
    di Celle PF, Reato G, Raspadori D, Carbone A, Rondelli D, Lauria F, Foà R.
    Leuk Lymphoma; 1994; 14 Suppl 1():139-42. PubMed ID: 7820046
    [Abstract] [Full Text] [Related]

  • 3. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine.
    Konwalinka G, Schirmer M, Hilbe W, Fend F, Geisen F, Knoblechner A, Petzer A, Thaler J.
    Blood Cells Mol Dis; 1995; 21(2):142-51. PubMed ID: 8846043
    [Abstract] [Full Text] [Related]

  • 4. Immunomorphologic analysis of bone marrow biopsies after treatment with 2-chlorodeoxyadenosine for hairy cell leukemia.
    Ellison DJ, Sharpe RW, Robbins BA, Spinosa JC, Leopard JD, Saven A, Piro LD.
    Blood; 1994 Dec 15; 84(12):4310-5. PubMed ID: 7994047
    [Abstract] [Full Text] [Related]

  • 5. Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatment.
    Bastie JN, Cazals-Hatem D, Daniel MT, D'Agay MF, Rabian C, Glaisner S, Noel-Walter MP, Dabout D, Flandrin G, Dombret H, Poisson D, Degos L, Castaigne S.
    Leuk Lymphoma; 1999 Nov 15; 35(5-6):555-65. PubMed ID: 10609793
    [Abstract] [Full Text] [Related]

  • 6. [Monitoring minimal residual disease in patients with hairy cell leukemia in complete remission after treatment with 2-chlorodioxyadenosine].
    Zák P, Chrobák L, Dĕdic K, Podzimek K.
    Vnitr Lek; 2000 Oct 15; 46(10):697-703. PubMed ID: 11344629
    [Abstract] [Full Text] [Related]

  • 7. Unexpectedly high incidence of hypoplastic/aplastic foci in bone marrow biopsies of hairy cell leukemia patients in remission following 2-chlorodeoxyadenosine therapy.
    Gillis S, Amir G, Bennett M, Polliack A.
    Eur J Haematol; 2001 Jan 15; 66(1):7-10. PubMed ID: 11168501
    [Abstract] [Full Text] [Related]

  • 8. A single course of 2-chloro-deoxyadenosine does not eradicate leukemic cells in hairy cell leukemia patients in complete remission.
    Filleul B, Delannoy A, Ferrant A, Zenebergh A, Van Daele S, Bosly A, Doyen C, Mineur P, Glorieux P, Driesschaert P.
    Leukemia; 1994 Jul 15; 8(7):1153-6. PubMed ID: 7913513
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine.
    Jehn U, Bartl R, Dietzfelbinger H, Haferlach T, Heinemann V.
    Leukemia; 2004 Sep 15; 18(9):1476-81. PubMed ID: 15229616
    [Abstract] [Full Text] [Related]

  • 13. Detection of minimal residual disease by immunostaining of bone marrow biopsies after 2-chlorodeoxyadenosine for hairy cell leukemia.
    Hakimian D, Tallman MS, Kiley C, Peterson L.
    Blood; 1993 Sep 15; 82(6):1798-802. PubMed ID: 7691237
    [Abstract] [Full Text] [Related]

  • 14. Simultaneous diagnosis of hairy cell leukemia and chronic lymphocytic leukemia/small lymphocytic lymphoma: a frequent association?
    Giné E, Bosch F, Villamor N, Rozman M, Colomer D, López-Guillermo A, Campo E, Montserrat E.
    Leukemia; 2002 Aug 15; 16(8):1454-9. PubMed ID: 12145685
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cladribine (2-chlorodeoxyadenosine) therapy in hairy cell leukemia variant. A report of three cases.
    Palomera L, Domingo JM, Sola C, Azaceta G, Calvo MT, Gutierrez M.
    Haematologica; 2002 Jan 15; 87(1):107-8. PubMed ID: 11801472
    [No Abstract] [Full Text] [Related]

  • 17. [Bone marrow changes in patients with hairy cell leukemia after 2-chlorodeoxyadenosine treatment].
    Urasiński I, Zdziarska B, Krygier-Stojałowska A.
    Acta Haematol Pol; 1996 Jan 15; 27(1):49-55. PubMed ID: 8629443
    [Abstract] [Full Text] [Related]

  • 18. Assessment of complete remission after 2-chlorodeoxyadenosine for hairy cell leukemia: utility of marrow immunostaining and measurement of splenic index.
    Tallman MS, Hakimian D, Dyrda S, Kiley C, Nemcek A, Peterson L.
    Leuk Lymphoma; 1994 Jan 15; 14 Suppl 1():133-8. PubMed ID: 7529609
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.